121041-62-1

Basic information

• Product Name: 3-Pyridazinamine, 6-[[(4-methoxyphenyl)methyl]thio]-
• Synonyms: 3-Pyridazinamine, 6-[[(4-methoxyphenyl)methyl]thio]-
• CAS NO: 121041-62-1
• Molecular Formula: C₁₂H₁₃N₃OS
• Molecular Weight: 247.31612
• Mol File: 121041-62-1.mol
• Article Data: 1

Chemical Properties

• Boiling Point: 505.2°Cat760mmHg
• Flash Point: 259.3°C
• Appearance: /
• Density: 1.28g/cm³
• Vapor Pressure: 2.48E-10mmHg at 25°C
• Refractive Index: 1.645
• PKA: 4.55±0.10(Predicted)
• CAS DataBase Reference: 3-Pyridazinamine, 6-[[(4-methoxyphenyl)methyl]thio]-(CAS DataBase Reference)
• NIST Chemistry Reference: 3-Pyridazinamine, 6-[[(4-methoxyphenyl)methyl]thio]-(121041-62-1)
• EPA Substance Registry System: 3-Pyridazinamine, 6-[[(4-methoxyphenyl)methyl]thio]-(121041-62-1)

Safety Data

• Hazardous Substances Data: 121041-62-1(Hazardous Substances Data)

Usage

General Description

3-Pyridazinamine, 6-[[(4-methoxyphenyl)methyl]thio]- is a chemical compound with the molecular formula C13H13N3OS. It is a thioether derivative of 3-pyridazinamine, and it contains a 4-methoxyphenylmethyl group attached to the sixth carbon of the pyridazine ring. 3-Pyridazinamine, 6-[[(4-methoxyphenyl)methyl]thio]- may have potential applications in pharmaceutical research and drug development due to its unique structural features and potential therapeutic properties. Its synthesis and detailed chemical properties may be of interest to researchers in the field of organic chemistry and medicinal chemistry.

InChI:InChI=1/C12H13N3OS/c1-16-10-4-2-9(3-5-10)8-17-12-7-6-11(13)14-15-12/h2-7H,8H2,1H3,(H2,13,14)

Upstream product

• 5469-69-2 6-chloro-pyridazin-3-ylamine 
• 6258-60-2 p-methoxybenzylmercaptan 

Downstream Products

• 144449-04-7 2-benzyl-6-(4'-methoxybenzylthio)imidazo<1,2-b>pyridazine 
• 144449-29-6 3-dimethylaminomethyl-6-(4'-methoxybenzylthio)-2-phenethylimidazo<1,2-b>pyridazine 
• 144449-23-0 2-benzyl-3-dimethylaminomethyl-6-(4'-methoxybenzylthio)imidazo<1,2-b>pyridazine 
• 144448-68-0 3-methoxy-6-(4'-methoxybenzylthio)-2-phenethylimidazo<1,2-b>pyridazine 
• 144448-45-3 2-benzyl-3-methoxy-6-(4'-methoxybenzylthio)imidazo<1,2-b>pyridazine 
• 121041-09-6 3-methoxy-6-(4'-methoxybenzylthio)-2-phenylimidazo<1,2-b>pyridazine 
• 121041-11-0 6-(3'-methoxybenzylthio)-2-phenylimidazo<1,2-b>pyridazine 
• 144449-12-7 6-(4'-methoxybenzylthio)-2-phenethylimidazo<1,2-b>pyridazine 

Relevant articles and documents

Imidazopyridazines. VI. Syntheses and Central Nervous System Activities of Some 6-(Alkoxy- and methylthio-phenoxy and methoxybenzylthio)-3-methoxy-2-phenyl(substituted phenyl and pyridinyl)imidazopyridazines

Series of 6-(alkoxy- and methylthio-phenoxy)-2-phenyl(substituted phenyl and pyridinyl)imidazopyridazines and 3-methoxy-6-(methoxybenzylthio)-2-phenyl(substituted phenyl and pyridinyl)imidazopyridazines have been prepared and subsesquently tested for their ability to inhibit GABA-stimulated 3H-diazepam binding to rat brain plasma membranes.The 6-(alkoxy- and methylthio-phenoxy) and 6-(methoxybenzylthio) compounds were much more effective in the displacement studies than the parent 6-phenoxy or 6-benzylthio compounds respectively.3-Methoxy-6-(2'-methoxyphenoxy)-2-phenylimidazopyridazine (GBLD-167, IC50 70 nM) was 16 times more effective than its 3-methoxy-6-phenoxy analogue (GBLD-214, IC50 1120 nM) and the 3-methoxy-6-(2'-methoxybenzylthio)-2-phenyl compound (GBLD-163, IC50 9 nM) was two and a half times more active than its 6-benzylthio-3-methoxy analogue (GBLD-137, IC50 22nM).The most active member of the 6-phenoxy series was the 2-(4'-fluorophenyl)-3-methoxy-6-(2''-methoxyphenoxy) compound (GBLD-255, IC50 30nM) and, within the 6-benzylthio series, the 2-(4'-fluorophenyl, 3'-aminophenyl, and pyridin-3'-yl)-3-methoxy-6-(3''-methoxybenzylthio) compounds (GBLD-233, 301 and 296) all gave IC50 5nM.A Hansch-type analysis of the results for these two closely related series of compounds indicates that electron-donating substituents in 2-(para substituted phenyl) derivatives favour binding, but bulky substituents hinder this effect.